Covered recipient · General Payments record
TORRY MIQUEL PLEDGER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$469.38
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $469.38 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $158.41 | 4 |
| SHIELD THERAPEUTICS INC | $142.50 | 2 |
| PFIZER INC. | $53.09 | 3 |
| Hologic Sales and Service, LLC | $43.86 | 2 |
| ITI, Inc. | $24.61 | 1 |
| Novo Nordisk AS | $17.30 | 1 |
| GlaxoSmithKline, LLC. | $16.09 | 1 |
| Lilly USA, LLC | $13.52 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $469.38 | 15 |
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $11.70 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657117 | CMS |
| Amgen Inc. | $122.53 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116022094 | CMS |
| Amgen Inc. | $11.46 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657119 | CMS |
| Amgen Inc. | $12.72 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657121 | CMS |
| GlaxoSmithKline, LLC. | $16.09 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191209 | CMS |
| Hologic Sales and Service, LLC | $21.59 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084907406 | CMS |
| Hologic Sales and Service, LLC | $22.27 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084907442 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24.61 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143297371 | CMS |
| Lilly USA, LLC | $13.52 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135467547 | CMS |
| Novo Nordisk Inc | $17.30 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096926724 | CMS |
| PFIZER INC. | $16.59 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131568151 | CMS |
| PFIZER INC. | $18.96 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131572791 | CMS |
| PFIZER INC. | $17.54 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131518786 | CMS |
| SHIELD THERAPEUTICS INC | $88.24 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150147005 | CMS |
| SHIELD THERAPEUTICS INC | $54.26 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150151522 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.